Moderation of hemophilia A phenotype by the factor V R506Q mutation

Blood

Volumn 88, Issue 4, 1996, Pages 1183-1187

  Nichols, William C ^a   Amano, Kagehiro ^a   Cacheris, Phillip M ^a   Figueiredo, Mauro S ^a   Michaelides, Katerina ^a   Schwaab, Rainer ^a   Hoyer, Leon ^a   Kaufman, Randal J ^a   Ginsburg, David ^a  

^a 4520 MSRB 1 ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE LOCUS; HEMOPHILIA A; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR GENETICS; PHENOTYPE; POINT MUTATION; PREDICTION; PRIORITY JOURNAL; PROTEIN MODIFICATION;

EID: 0029820281     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.4.1183.bloodjournal8841183     Document Type: Article

References (35)

1. Tuddenham EGD, Schwaab R, Seehafer J, Millar DS, Gitschier J, Higuchi M, Bidichandani S, Connor JM, Hoyer LW, Yoshioka A, Peake IR, Olek K, Kazazian HH, Lavergne J-M, Giannelli F, Antonarakis SE, Cooper DN: Haemophilia A: Database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition. Nucleic Acids Res 22:3511, 1994
2. Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J: Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 5:236, 1993
3. Hoyer LW: Hemophilia A. N Engl J Med 330:38, 1994
4. Berg L-P, Varon D, Martinowitz U, Wieland K, Kakkar VV, Cooper DN: Combined factor VIII/factor XI deficiency may cause intra-familial clinical variability in haemophilia A among Ashkenazi Jews. Blood Coagul Fibrinolysis 5:59, 1994
5. Cacheris PM, Nichols WC, Ginsburg D: Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction. J Biol Chem 266:13499, 1991
6. Mazurier C: von Willebrand disease masquerading as haemophilia A. Thromb Haemost 67:391, 1992
7. Kroner PA, Friedman KD, Fahs SA, Scott JP, Montgomery RR: Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem 266:19146, 1991
8. Tuley EA, Gaucher C, Jorieux S, Worrall NK, Sadler JE, Mazurier C: Expression of von Willebrand factor "Normandy": An autosomal mutation that mimics hemophilia A. Proc Natl Acad Sci USA 88:6377, 1991
9. Eikenboom JCJ, Reitsma PH, Peerlinck KMJ, Briët E: Recessive inheritance of von Willebrand's disease type I. Lancet 341:982, 1993
10. Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004, 1993
11. Dahlbäck B: Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 94:923, 1994
12. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
13. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503, 1993
14. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912, 1995
15. Pittman DD, Millenson M, Marquette K, Bauer K, Kaufman RJ: A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage. Blood 79:389, 1992
16. Gitschier J, Kogan S, Levinson B, Tuddenham EGD: Mutations of factor VIII cleavage sites in hemophilia A. Blood 72:1022, 1988
17. Arai M, Higuchi M, Antonarakis SE, Kazazian HH Jr, Phillips JA III, Janco RL, Hoyer LW: Characterization of a thrombin cleavage site mutation (Arg 1689 to Cys) in the factor VIII gene of two unrelated patients with cross-reacting material-positive hemophilia A. Blood 75:384, 1990
18. Schwaab R, Ludwig M, Oldenburg J. Brackmann HH, Egli H, Kochhan L, Olek K: Identical point mutations in the factor VIII gene that have different clinical manifestations of hemophilia A. Am J Hum Genet 47:743, 1990
19. Levinson B, Lehesjoki A-E, de la Chapelle A, Gitschier J: Molecular analysis of hemophilia A mutations in the Finnish population. Am J Hum Genet 46:53, 1990
20. Figueiredo MS, Brownlee GG: cis-acting elements and transcription factors involved in the promoter activity of the human factor VIII gene. J Biol Chem 270:11828, 1995
21. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG: Inherited predisposition to thrombosis. Cell 72:477, 1993
22. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM: Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 84:1031, 1994
23. Lian EC-Y, Deykin D, Harkness DR: Combined deficiencies of factor VIII (AHF) and factor XI (PTA). Am J Hematol 1:319, 1976
24. Tavori S, Brenner B, Tatarsky I: The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis. Thromb Haemost 63:36, 1990
25. Chediak J, Lambert E, Johnson EI, Telfer MC: Combined severe factor XI deficiency and von Willebrand's disease. Am J Clin Pathol 74:108, 1980
26. Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B: Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 85:3518, 1995
27. Ginsburg D, Bowie EJW: Molecular genetics of von Willebrand disease. Blood 79:2507, 1992
28. 506 has no dominant influence on the severity of hemophilia when inherited concurrently. Thromb Haemost 73:1368, 1995
29. Arbini AA, Mannucci PM, Bauer KA: Low prevalence of the factor V leiden mutation among "severe" hemophilics with a "milder" bleeding diathesis. Thromb Haemost 74:1255, 1995
30. R506Q. J Biol Chem 270:4053, 1995
31. 506-factor V. Blood 85:3405, 1995
32. R506Q by activated protein C. J Biol Chem 270:21158, 1995
33. Kalafatis M, Rand MD, Mann KG: The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869, 1994
34. Shen L, Dahlbäck B: Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor Villa. J Biol Chem 269:18735, 1994
35. Kalafatis M, Lu DS, Bertina RM, Long GL, Mann KG: Biochemical prototype for familial thrombosis - A study combining a functional protein C mutation and factor V Leiden. Arterioscler Thromb Vase Biol 15:2181, 1995